Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...

For people with sensitivity, encountering an allergen can within seconds turn into a respiratory emergency. This is what you ...

This strategic move brings stability to Embecta, addressing challenges faced since its spin-off from Becton Dickinson & Co.

Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.

Alerje founder Javier Evelyn’s mobile auto-injector platform was recently acquired by SemPresto.

Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 PM EDTCompany ParticipantsWilliam Peters - ...

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsBrian Lian - President, CEO ...

MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help ...

Executives from Celldex Therapeutics (NASDAQ:CLDX) outlined a busy year of clinical and development milestones at the TD ...

Argenx delivered Q4 2025 product net sales of $1.3B and $4.2B for the full year, up 90% year over year as VYVGART demand accelerated globally. The company reported Q4 operating profit of $367M and ...

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with “solid” results and entered 2026 with ...